APA (7th ed.) Citation

XY, W., XM, Z., L, W., LR, G., K, C., XL, F., . . . SN, Q. (2025). Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: A multicentre, single-arm, phase 2 trial. The Lancet. Haematology, 12(6), e442. https://doi.org/10.1016/S2352-3026(25)00071-7

Chicago Style (17th ed.) Citation

XY, Wang, et al. "Low-dose Moderate Hypofractionated Radiotherapy for Indolent Non-Hodgkin Lymphoma: A Multicentre, Single-arm, Phase 2 Trial." The Lancet. Haematology 12, no. 6 (2025): e442. https://doi.org/10.1016/S2352-3026(25)00071-7.

MLA (9th ed.) Citation

XY, Wang, et al. "Low-dose Moderate Hypofractionated Radiotherapy for Indolent Non-Hodgkin Lymphoma: A Multicentre, Single-arm, Phase 2 Trial." The Lancet. Haematology, vol. 12, no. 6, 2025, p. e442, https://doi.org/10.1016/S2352-3026(25)00071-7.